Efficacy and Safety of Silodosin in the Treatment of Lower Urinary Tract Symptoms in Taiwanese Population.

Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder.

NCT01093534 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Silodosin on Voiding Dysfunction Associated With Neurogenic Bladder

NCT01228370 ·Status: COMPLETED ·Phase: PHASE4

Studies of Psychiatric Predisposing Factors, Treatment-related Cardiovascular Effects, and Prognostic Factors Associated With Antimuscarinic Drug (Tolterodine) for Female Overactive Bladder Syndrome

NCT01503580 ·Status: COMPLETED ·Phase: NA

Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis

NCT00629642 ·Status: COMPLETED ·Phase: PHASE4

Predictors Affecting Long-term Use of Solifenacin or Mirabegron in Women With Overactive Bladder Syndrome

NCT05040984 ·Status: UNKNOWN

Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan

NCT03044912 ·Status: UNKNOWN ·Phase: PHASE3

A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive Bladder

NCT03566134 ·Status: COMPLETED ·Phase: PHASE2

Comparisons of 3-month Versus 6-month Solifenacin Treatment for Female OAB Patients

NCT01876186 ·Status: UNKNOWN ·Phase: PHASE4

A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China

NCT03572231 ·Status: COMPLETED

The Effect of Nighttime Mirabegron, Solifenacin, Tolterodine, or Oxybutynin on Nocturia, Sexual Function, Autonomic Function, and Lower Urinary Tract Blood Flow Perfusion in Women With Overactive Bladder Syndrome: Randomized Controlled Trial

NCT07114640 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Comparing Treatments for Overactive Bladder in Taiwan: A Study of Outcomes

NCT07025642 ·Status: RECRUITING ·Phase: NA

Tamsulosin Phase III Clinical Trial -Double-Blind, Placebo Controlled Study in Female Patients With Lower Urinary Tract Syndrome

NCT00239265 ·Status: COMPLETED ·Phase: PHASE3

Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug

NCT01627145 ·Status: UNKNOWN ·Phase: NA

Comparison of the Transcutaneous Tibial Nerve Stimulation and Drug Treatment' Effects in Women With Overactive Bladder

NCT06024005 ·Status: COMPLETED ·Phase: NA

A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Participants 5 to 18 Years of Age With Neurogenic Detrusor Overactivity

NCT01565694 ·Status: COMPLETED ·Phase: PHASE3

Tamsulosin Phase III Clinical Trial -Double-Blind, Placebo Controlled Study in Male Patients With Lower Urinary Tract Syndrome

NCT00239317 ·Status: COMPLETED ·Phase: PHASE3

Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan

NCT03059134 ·Status: COMPLETED ·Phase: PHASE3

Solifenacin Succinate 5mg or 10mg Once Daily in the Treatment of Urgency Symptoms

NCT00801944 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Study to Investigate How Solifenacin Fluid is Taken up, How Long it Stays in the Body and How Effective and Safe it is in Treating Children Aged From 6 Months to Less Than 5 Years With Symptoms of Neurogenic Detrusor Overactivity (NDO)

NCT01981954 ·Status: COMPLETED ·Phase: PHASE3

The Efficacy of Solifenacin With or Without Tamsulosin in Adult Women With Overactive Bladder (OAB)

NCT01533597 ·Status: COMPLETED ·Phase: PHASE4

Exploratory Trial of TAS-303 in Female Patients With Stress Urinary Incontinence

NCT02906683 ·Status: COMPLETED ·Phase: PHASE2

Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder.

NCT03175029 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Study of TAS-303 in Female Patients With Stress Urinary Incontinence

NCT04512053 ·Status: COMPLETED ·Phase: PHASE2

Myrbetriq™ (Mirabegron) to Improve Disordered Sleep in Subjects With Lower Urinary Tract Symptoms (LUTS)

NCT02410135 ·Status: COMPLETED

Efficacy and Safety of OROS Oybutynin and TTS Oxybutynin in Middle-Aged and Elderly Women With Urinary Incontinence

NCT00304499 ·Status: COMPLETED ·Phase: PHASE3